SuviCA suvica.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

SuviCa is focused on the discovery and development of small molecules for the treatment of cancer. Currently, SuviCa has two small molecule protein synthesis inhibitors in pre-clinical development. SVC112 – With a patent filed for Composition of Matter protection, SVC112 has shown pre-clinical efficacy as monotherapy and in combination with standard therapies such as radiation and newly approved targeted agents. SVC112 is in pre-clinical development for a variety of cancer indications, includi...Show all

SuviCa is focused on the discovery and development of small molecules for the treatment of cancer. Currently, SuviCa has two small molecule protein synthesis inhibitors in pre-clinical development. SVC112 – With a patent filed for Composition of Ma...Show all

Company (Alive / Active)

All investors data 1 Investors

Phone: 303-921-6680

Fax:

PO Box 3131

 Boulder, 80307
 Colorado, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
SuviCA $1.5M Oct 15, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related SuviCA Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Bouvardin derivatives and therapeutic uses thereof Aug 10, 2016 Apr 16, 2019 Patent
Bourvadin derivatives and therapeutic uses thereof Feb 21, 2013 Sep 27, 2016 Patent